Belite Bio (BLTE) Non-cash Items (2020 - 2025)

Belite Bio (BLTE) recorded quarterly Non-cash Items of $2.3 million in Q4 2025, down 99.16% quarter-over-quarter from $273.4 million in Q4 2024, and down 99.16% on a YoY basis from $273.4 million in Q4 2024.

Belite Bio (BLTE) Non-cash Items (2020 - 2025) Analysis & Trends

Belite Bio's Non-cash Items history runs 6 years deep, the most recent figure standing at $2.3 million for Q4 2025.

  • In Q4 2025, Non-cash Items fell 99.16% year-over-year to $2.3 million; the TTM figure through Dec 2025 stood at $2.3 million (down 99.16% YoY), while the FY2025 annual figure was $2.3 million, down 99.16% from the prior year.
  • Non-cash Items was $2.3 million for Q4 2025 at Belite Bio, down from $273.4 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $273.4 million in Q4 2024 to a low of $2.3 million in Q4 2025.
  • Historically, Non-cash Items has averaged $64.3 million across 5 years, with a median of $10.5 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Non-cash Items jumped 778.71% in 2024, then tumbled 99.16% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $4.5 million in 2021, then jumped by 133.77% to $10.5 million in 2022, then jumped by 197.04% to $31.1 million in 2023, then soared by 778.71% to $273.4 million in 2024, then sank by 99.16% to $2.3 million in 2025.
  • The last three Non-cash Items figures came in at $2.3 million (Q4 2025), $273.4 million (Q4 2024), and $31.1 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.29 Mn
Dec 31, 2025 2.29 Mn
Dec 31, 2024 273.36 Mn
Dec 31, 2024 273.36 Mn
Dec 31, 2023 31.11 Mn
Dec 31, 2023 31.11 Mn
Dec 31, 2022 10.47 Mn
Dec 31, 2022 10.47 Mn
Dec 31, 2021 4.48 Mn
Dec 31, 2021 4.48 Mn
Dec 31, 2020 7.83 Mn
Dec 31, 2020 7.83 Mn